Table 4 Comparison of the use of medications between clinics with heart failure with preserved ejection fraction (EF > 40) patients
Use of medications | Total (n = 239) | MACS (n = 166) | GCHFS (n = 73) | P-value |
|---|---|---|---|---|
ACEIs use | 94 (39.3) | 71 (43.0) | 23 (31.5) | .101 |
ARB use | 64 (27.0) | 46 (28.0) | 18 (25.0) | .623 |
ACEIs/ARBs | 155 (65.0) | 117 (70.5) | 41 (56.2) | 0.0314* |
β-blockers use | 139 (58.2) | 89 (54.0) | 50 (68.5) | .032* |
MRA use | 85 (35.6) | 50 (30.1) | 35 (48.0) | .008** |
Furosemide | 208 (87.0) | 139 (84.0) | 69 (94.5) | .022* |
Digoxin used | 60 (25.1) | 42 (25.3) | 18 (25.0) | .916 |
Contraindications for anticoagulation in AF | 12 (5.0) | 10 (6.0) | 2 (3.0) | .006** |
Anticoagulated in presence of AF without contraindications | 80 (33.5) | 45 (27.1) | 35 (48.0) | .002** |